Adult- PO- Initial- The recommended starting dose is 1-2 mg once daily, with food. Maximum: 2mg/day. Caution should be exercised in patients with history of liver and kidney disease, ketoacidosis, ...

Long-term use of glimepiride may improve survival and reduce hospitalizations in hospitalized patients with concomitant type 2 diabetes and chronic HF, researchers reported. In addition, high-dose ...

Objective: The aim of the present study was to monitor the efficacy and tolerability of glimepiride in daily practice. Design: An 8-week non-interventional cohort study investigating glimepiride in ...

Rosiglitazone (as maleate), glimepiride; 4mg/1mg, 4mg/2mg, 4mg/4mg, 8mg/2mg, 8mg/4mg; tabs. ≥18yrs: Take once daily with first meal of the day. Drug-naive: 4mg/1mg. Previously on thiazolidinedione ...

People with type 2 diabetes treated with metformin plus a sulfonylurea with high affinity for cardiac mitochondrial adenosine triphosphate–sensitive potassium (mitoK ATP) channels, such as glyburide ...

Sulfonylureas are often added to metformin to improve glycemic control, but at the known risk of increasing hypoglycemia and weight gain. In a report published in the Lancet, more than 1,500 patients ...

Heart Failure Linked to Loss of Cerebral Gray Matter The dipeptidyl peptidase-4 inhibitor linagliptin is noninferior to the sulphonylurea glimepiride for second-line glycemic control and is associated ...

New Delhi : Mascot Health Series Pvt.Ltd has received the Drug Controller General of India’s (DCGI) approval for its triple combination diabetes treatment. Mascot claims to be the first CDMO to launch ...